Medical Bulletin 06/September/2023 Isra Zaman6 Sept 2023 3:15 PM ISTHere are the top medical news of the day:New Covid Variant ‘Pirola' raising alarm Public health experts are expressing concern about a novel...
Statins linked to lower risk of colorectal cancer in patients with ulcerative colitis Isra Zaman6 Sept 2023 9:30 AM ISTCholesterol-lowering statins might protect patients with ulcerative colitis from developing and dying from colorectal cancer. Statin treatment was...
Tofacitinib Effective both short-term and long-term in patients with Ulcerative Colitis Jacinthlyn Sylvia5 Sept 2023 9:00 AM ISTIn a recent study published in the American Journal of Gastroenterology the efficacy, durability, and safety of tofacitinib in treating ulcerative...
Use of lipid-lowering drugs may increase risk of inflammatory bowel disease Dr. Kamal Kant Kohli8 Aug 2023 11:15 AM ISTChina: A recent study published in the European Journal of Clinical Investigation has shed light on the association between the use of lipid-lowering...
Aurobindo Pharma arm CuraTeQ Biologics to commercialize proposed biosimilar to Stelara Ruchika Sharma8 July 2023 12:00 PM ISTCuraTeQ intends to file this product in India and Emerging Markets as early as in 2024 and the regulated markets filing is expected to begin in 2026.
Mirikizumab Highly Effective in Treating Ulcerative Colitis and safely Maintaining Remission: NEJM Aditi2 July 2023 8:00 PM ISTAn original article entitled "Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis", published in the New England Journal of...
Zydus gets USFDA nod for bowel disease drug Balsalazide Disodium Ruchika Sharma10 Jun 2023 3:17 PM ISTThe product will be manufactured at the group’s formulation manufacturing facility in SEZ, Ahmedabad, India.
AstraZeneca discontinues brazikumab inflammatory bowel disease development programme Ruchika Sharma2 Jun 2023 1:30 PM ISTCambridge: AstraZeneca has announced the discontinuation of the brazikumab inflammatory bowel disease (IBD) development programme, an anti-IL-23...
FDA approves Upadacitinib for Crohn's disease in adults Dr. Kamal Kant Kohli19 May 2023 10:00 AM ISTThe U.S. Food and Drug Administration (FDA) has approved Upadacitinib for treatment of adults with moderately to severely active Crohn's disease...
Melatonin use may impair action of gut microbiota and worsen IBD Dr. Kamal Kant Kohli10 May 2023 8:00 PM ISTBrazil: Melatonin can worsen the inflammation of the intestine and impair the action of gut microbiota despite its antioxidant effects and role in...
Etrasimod effective induction and maintenance therapy for moderate to severe active ulcerative colitis Aditi19 April 2023 8:00 PM ISTUSA: A study published in The Lancet has concluded for patients which a history of moderate to severe active ulcerative colitis, Etrasimod is proven...
Vedolizumab effective for inducing remission in patients with chronic pouchitis: Phase 4 trial Medha Baranwal3 April 2023 9:30 AM ISTUK: In patients with ulcerative colitis who undergo colectomy, restorative proctocolectomy with ileal pouch-anal anastomosis (IPAA) is routinely...
